コンテンツへスキップ
Merck

Worsening of contact dermatitis by oral hydroxyzine: a case report.

Dermatology online journal (2013-03-12)
Nianda Reid, Sunit Jariwala, Golda Hudes, Jason Fodeman, Elina Jerschow, David Rosenstreich
要旨

Hydroxyzine is commonly used to treat pruritic skin lesions. Although rare, hydroxyzine can sometimes be linked to worsening dermatitis in patients who have sensitivities to phenothiazines and/or ethylenediamines. Herein we describe a patient who developed papulovesicular eruptions following the use of topical neomycin. Our patient's contact dermatitis initially improved after the use of oral steroids. However, the patient's skin condition was exacerbated by the continued use of hydroxyzine to treat her pruritus. Patch testing was positive at 48 hours for neomycin sulfate, ethylenediamine dihydrochloride, and p-phenylenediamine. Given the suspected cross-reactivity between hydroxyzine and ethylenediamine, hydroxyzine was discontinued and the patient's cutaneous symptoms improved. In summary, physicians must be aware that oral hydroxyzine can worsen contact dermatitis in ethylenediamine-sensitive patients.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ネオマイシン 三硫酸塩 水和物, powder
Sigma-Aldrich
ネオマイシン 三硫酸塩 水和物, powder, BioReagent, suitable for cell culture
Supelco
ネオマイシン 三硫酸塩 水和物, VETRANAL®, analytical standard
Sigma-Aldrich
ヒドロキシジン 二塩酸塩, ≥97%
Sigma-Aldrich
ネオマイシン 三硫酸塩 水和物, suitable for plant cell culture
Sigma-Aldrich
ネオマイシン 三硫酸塩 水和物, meets USP testing specifications, powder
硫酸ネオマイシン, European Pharmacopoeia (EP) Reference Standard